Cover Image
市場調查報告書

U5個國家心律管理設備市場預測

EU5 Cardiac Rhythm Management Market Outlook to 2020

出版商 GlobalData 商品編碼 304786
出版日期 內容資訊 英文 239 Pages
訂單完成後即時交付
價格
Back to Top
U5個國家心律管理設備市場預測 EU5 Cardiac Rhythm Management Market Outlook to 2020
出版日期: 2014年05月26日 內容資訊: 英文 239 Pages
簡介

本報告提供EU5個國家心律管理設備市場相關資料,提供心臟再同步化治療用設備(心臟整流去顫器及心律調節器),植入式心臟整流去顫器,植入式心電圖記錄計,心律調節器等各類別銷售額,銷售數的實際成果及預測,平均價格,企業佔有率,流通佔有率,再彙整主要企業簡介,開發中產品,主要的財務相關交易等最新資訊。

第1章 目錄

第2章 簡介

  • 報告的內容
  • 心律管理設備市場區分
  • 該報告對象市場定義

第3章 EU5個國家心律管理設備市場

  • 收益(實際成果及預測)
  • 各收益類別比較(實際成果及預測)
  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果及預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 企業佔有率:各收益

第4章 法國的心律管理設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第5章 德國的心律管理設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第6章 義大利的心律管理設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第7章 西班牙的心律管理設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第8章 英國的心律管理設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第9章 主要企業概要

  • Medtronic, Inc.
  • St. Jude Medical, Inc
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Sorin S.p.A.

第10章 開發中產品

第11章 最近的趨勢

  • 企業通訊
  • 財務發表
  • 法律規章
  • 其他重要的動向
  • 產品資訊
  • 策略及產業規劃

第12章 附錄

圖表

目錄
Product Code: GDMECR0100DB

GlobalData's new report, "EU5 Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the EU5 Cardiac Rhythm Management Market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiac Rhythm Management Market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Cardiac Rhythm Management Devices categories - Cardiac Resynchronisation Therapy, Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.
  • Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
  • 2012 company shares and distribution shares data for the market category.
  • Global corporate-level profiles of key companies operating within the EU5 Cardiac Rhythm Management Market.
  • Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation and BIOTRONIK SE & Co. KG.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Cardiac Rhythm Management Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Cardiac Rhythm Management Market, EU5

  • 3.1. Cardiac Rhythm Management Market, EU5, Revenue ($m), 2005-2020
  • 3.2. Cardiac Rhythm Management Market, EU5, Category Comparison by Revenue ($m), 2005-2020
  • 3.3. Cardiac Rhythm Management Market, EU5, Revenue ($m), 2005-2012
  • 3.4. Cardiac Rhythm Management Market, EU5, Revenue ($m), 2012-2020
  • 3.5. Cardiac Rhythm Management Market, EU5, Volume (Units), 2005-2020
  • 3.6. Cardiac Rhythm Management Market, EU5, Volume (Units), 2005-2012
  • 3.7. Cardiac Rhythm Management Market, EU5, Volume (Units), 2012-2020
  • 3.8. Cardiac Rhythm Management Market, EU5, Company Share by Revenue ($m), 2011-2012

4. Cardiac Rhythm Management Market, France

  • 4.1. Cardiac Rhythm Management Market, France, Revenue ($m), 2005-2012
  • 4.2. Cardiac Rhythm Management Market, France, Revenue ($m), 2012-2020
    • 4.2.1. Cardiac Resynchronisation Therapy Market, France, Revenue ($m), by Segment, 2005-2012
    • 4.2.2. Implantable Cardioverter Defibrillators Market, France, Revenue ($m), by Segment, 2005-2012
    • 4.2.3. Pacemakers Market, France, Revenue ($m), by Segment, 2005-2012
    • 4.2.4. Cardiac Resynchronisation Therapy Market, France, Revenue ($m), by Segment, 2012-2020
    • 4.2.5. Implantable Cardioverter Defibrillators Market, France, Revenue ($m), by Segment, 2012-2020
    • 4.2.6. Pacemakers Market, France, Revenue ($m), by Segment, 2012-2020
  • 4.3. Cardiac Rhythm Management Market, France, Volume (Units), 2005-2012
  • 4.4. Cardiac Rhythm Management Market, France, Volume (Units), 2012-2020
    • 4.4.1. Cardiac Resynchronisation Therapy Market, France, Volume (Units), by Segment, 2005-2012
    • 4.4.2. Implantable Cardioverter Defibrillators Market, France, Volume (Units), by Segment, 2005-2012
    • 4.4.3. Pacemakers Market, France, Volume (Units), by Segment, 2005-2012
    • 4.4.4. Cardiac Resynchronisation Therapy Market, France, Volume (Units), by Segment, 2012-2020
    • 4.4.5. Implantable Cardioverter Defibrillators Market, France, Volume (Units), by Segment, 2012-2020
    • 4.4.6. Pacemakers Market, France, Volume (Units), by Segment, 2012-2020
  • 4.5. Cardiac Rhythm Management Market, France, Average Price ($), 2005-2020
  • 4.6. Cardiac Rhythm Management Market, France, Distribution Share by Revenue ($m), 2011-2012
  • 4.7. Cardiac Rhythm Management Market, France, Company Share by Revenue ($m), 2011-2012

5. Cardiac Rhythm Management Market, Germany

  • 5.1. Cardiac Rhythm Management Market, Germany, Revenue ($m), 2005-2012
  • 5.2. Cardiac Rhythm Management Market, Germany, Revenue ($m), 2012-2020
    • 5.2.1. Cardiac Resynchronisation Therapy Market, Germany, Revenue ($m), by Segment, 2005-2012
    • 5.2.2. Implantable Cardioverter Defibrillators Market, Germany, Revenue ($m), by Segment, 2005-2012
    • 5.2.3. Pacemakers Market, Germany, Revenue ($m), by Segment, 2005-2012
    • 5.2.4. Cardiac Resynchronisation Therapy Market, Germany, Revenue ($m), by Segment, 2012-2020
    • 5.2.5. Implantable Cardioverter Defibrillators Market, Germany, Revenue ($m), by Segment, 2012-2020
    • 5.2.6. Pacemakers Market, Germany, Revenue ($m), by Segment, 2012-2020
  • 5.3. Cardiac Rhythm Management Market, Germany, Volume (Units), 2005-2012
  • 5.4. Cardiac Rhythm Management Market, Germany, Volume (Units), 2012-2020
    • 5.4.1. Cardiac Resynchronisation Therapy Market, Germany, Volume (Units), by Segment, 2005-2012
    • 5.4.2. Implantable Cardioverter Defibrillators Market, Germany, Volume (Units), by Segment, 2005-2012
    • 5.4.3. Pacemakers Market, Germany, Volume (Units), by Segment, 2005-2012
    • 5.4.4. Cardiac Resynchronisation Therapy Market, Germany, Volume (Units), by Segment, 2012-2020
    • 5.4.5. Implantable Cardioverter Defibrillators Market, Germany, Volume (Units), by Segment, 2012-2020
    • 5.4.6. Pacemakers Market, Germany, Volume (Units), by Segment, 2012-2020
  • 5.5. Cardiac Rhythm Management Market, Germany, Average Price ($), 2005-2020
  • 5.6. Cardiac Rhythm Management Market, Germany, Distribution Share by Revenue ($m), 2011-2012
  • 5.7. Cardiac Rhythm Management Market, Germany, Company Share by Revenue ($m), 2011-2012

6. Cardiac Rhythm Management Market, Italy

  • 6.1. Cardiac Rhythm Management Market, Italy, Revenue ($m), 2005-2012
  • 6.2. Cardiac Rhythm Management Market, Italy, Revenue ($m), 2012-2020
    • 6.2.1. Cardiac Resynchronisation Therapy Market, Italy, Revenue ($m), by Segment, 2005-2012
    • 6.2.2. Implantable Cardioverter Defibrillators Market, Italy, Revenue ($m), by Segment, 2005-2012
    • 6.2.3. Pacemakers Market, Italy, Revenue ($m), by Segment, 2005-2012
    • 6.2.4. Cardiac Resynchronisation Therapy Market, Italy, Revenue ($m), by Segment, 2012-2020
    • 6.2.5. Implantable Cardioverter Defibrillators Market, Italy, Revenue ($m), by Segment, 2012-2020
    • 6.2.6. Pacemakers Market, Italy, Revenue ($m), by Segment, 2012-2020
  • 6.3. Cardiac Rhythm Management Market, Italy, Volume (Units), 2005-2012
  • 6.4. Cardiac Rhythm Management Market, Italy, Volume (Units), 2012-2020
    • 6.4.1. Cardiac Resynchronisation Therapy Market, Italy, Volume (Units), by Segment, 2005-2012
    • 6.4.2. Implantable Cardioverter Defibrillators Market, Italy, Volume (Units), by Segment, 2005-2012
    • 6.4.3. Pacemakers Market, Italy, Volume (Units), by Segment, 2005-2012
    • 6.4.4. Cardiac Resynchronisation Therapy Market, Italy, Volume (Units), by Segment, 2012-2020
    • 6.4.5. Implantable Cardioverter Defibrillators Market, Italy, Volume (Units), by Segment, 2012-2020
    • 6.4.6. Pacemakers Market, Italy, Volume (Units), by Segment, 2012-2020
  • 6.5. Cardiac Rhythm Management Market, Italy, Average Price ($), 2005-2020
  • 6.6. Cardiac Rhythm Management Market, Italy, Distribution Share by Revenue ($m), 2011-2012
  • 6.7. Cardiac Rhythm Management Market, Italy, Company Share by Revenue ($m), 2011-2012

7. Cardiac Rhythm Management Market, Spain

  • 7.1. Cardiac Rhythm Management Market, Spain, Revenue ($m), 2005-2012
  • 7.2. Cardiac Rhythm Management Market, Spain, Revenue ($m), 2012-2020
    • 7.2.1. Cardiac Resynchronisation Therapy Market, Spain, Revenue ($m), by Segment, 2005-2012
    • 7.2.2. Implantable Cardioverter Defibrillators Market, Spain, Revenue ($m), by Segment, 2005-2012
    • 7.2.3. Pacemakers Market, Spain, Revenue ($m), by Segment, 2005-2012
    • 7.2.4. Cardiac Resynchronisation Therapy Market, Spain, Revenue ($m), by Segment, 2012-2020
    • 7.2.5. Implantable Cardioverter Defibrillators Market, Spain, Revenue ($m), by Segment, 2012-2020
    • 7.2.6. Pacemakers Market, Spain, Revenue ($m), by Segment, 2012-2020
  • 7.3. Cardiac Rhythm Management Market, Spain, Volume (Units), 2005-2012
  • 7.4. Cardiac Rhythm Management Market, Spain, Volume (Units), 2012-2020
    • 7.4.1. Cardiac Resynchronisation Therapy Market, Spain, Volume (Units), by Segment, 2005-2012
    • 7.4.2. Implantable Cardioverter Defibrillators Market, Spain, Volume (Units), by Segment, 2005-2012
    • 7.4.3. Pacemakers Market, Spain, Volume (Units), by Segment, 2005-2012
    • 7.4.4. Cardiac Resynchronisation Therapy Market, Spain, Volume (Units), by Segment, 2012-2020
    • 7.4.5. Implantable Cardioverter Defibrillators Market, Spain, Volume (Units), by Segment, 2012-2020
    • 7.4.6. Pacemakers Market, Spain, Volume (Units), by Segment, 2012-2020
  • 7.5. Cardiac Rhythm Management Market, Spain, Average Price ($), 2005-2020
  • 7.6. Cardiac Rhythm Management Market, Spain, Distribution Share by Revenue ($m), 2011-2012
  • 7.7. Cardiac Rhythm Management Market, Spain, Company Share by Revenue ($m), 2011-2012

8. Cardiac Rhythm Management Market, United Kingdom

  • 8.1. Cardiac Rhythm Management Market, United Kingdom, Revenue ($m), 2005-2012
  • 8.2. Cardiac Rhythm Management Market, United Kingdom, Revenue ($m), 2012-2020
    • 8.2.1. Cardiac Resynchronisation Therapy Market, United Kingdom, Revenue ($m), by Segment, 2005-2012
    • 8.2.2. Implantable Cardioverter Defibrillators Market, United Kingdom, Revenue ($m), by Segment, 2005-2012
    • 8.2.3. Pacemakers Market, United Kingdom, Revenue ($m), by Segment, 2005-2012
    • 8.2.4. Cardiac Resynchronisation Therapy Market, United Kingdom, Revenue ($m), by Segment, 2012-2020
    • 8.2.5. Implantable Cardioverter Defibrillators Market, United Kingdom, Revenue ($m), by Segment, 2012-2020
    • 8.2.6. Pacemakers Market, United Kingdom, Revenue ($m), by Segment, 2012-2020
  • 8.3. Cardiac Rhythm Management Market, United Kingdom, Volume (Units), 2005-2012
  • 8.4. Cardiac Rhythm Management Market, United Kingdom, Volume (Units), 2012-2020
    • 8.4.1. Cardiac Resynchronisation Therapy Market, United Kingdom, Volume (Units), by Segment, 2005-2012
    • 8.4.2. Implantable Cardioverter Defibrillators Market, United Kingdom, Volume (Units), by Segment, 2005-2012
    • 8.4.3. Pacemakers Market, United Kingdom, Volume (Units), by Segment, 2005-2012
    • 8.4.4. Cardiac Resynchronisation Therapy Market, United Kingdom, Volume (Units), by Segment, 2012-2020
    • 8.4.5. Implantable Cardioverter Defibrillators Market, United Kingdom, Volume (Units), by Segment, 2012-2020
    • 8.4.6. Pacemakers Market, United Kingdom, Volume (Units), by Segment, 2012-2020
  • 8.5. Cardiac Rhythm Management Market, United Kingdom, Average Price ($), 2005-2020
  • 8.6. Cardiac Rhythm Management Market, United Kingdom, Distribution Share by Revenue ($m), 2011-2012
  • 8.7. Cardiac Rhythm Management Market, United Kingdom, Company Share by Revenue ($m), 2011-2012

9. Overview of Key Companies in EU5 Cardiac Rhythm Management Market

  • 9.1. Medtronic, Inc.
    • 9.1.1. Company Overview
  • 9.2. St. Jude Medical, Inc.
    • 9.2.1. Company Overview
  • 9.3. Boston Scientific Corporation
    • 9.3.1. Company Overview
  • 9.4. Biotronik SE & Co. KG
    • 9.4.1. Company Overview
  • 9.5. Sorin S.p.A.
    • 9.5.1. Company Overview

10. Cardiac Rhythm Management Market Pipeline Products

11. Recent Developments

  • 11.1. Corporate Communications
    • 11.1.1. May 05, 2014: Mark A. Heggestad Joins Orthofix as New Chief Financial Officer
    • 11.1.2. Apr 25, 2014: Orthofix Appoints James F. Hinrichs to its Board of Directors
    • 11.1.3. Apr 21, 2014: Orthofix Appoints David Ziegler as Interim CFO
    • 11.1.4. Mar 20, 2014: Orthofix Appoints Ronald A. Matricaria as New Chairman of the Board
    • 11.1.5. Feb 12, 2014: Orthofix Receives Expected NASDAQ Notice
    • 11.1.6. Feb 05, 2014: Orthofix Provides Update on NASDAQ Listing Status
    • 11.1.7. Jan 23, 2014: Orthofix Appoints Kathleen Regan as Interim Chair of the Board
    • 11.1.8. Dec 03, 2013: Orthofix Appoints Dr. Anthony F. Martin to its Board of Directors
    • 11.1.9. Nov 22, 2013: Orthofix Provides Update Regarding NASDAQ Listing Matters
    • 11.1.10. Nov 22, 2013: Orthofix provides update regarding Nasdaq listing matters
    • 11.1.11. Nov 06, 2013: Orthofix Appoints Two New Independent Board Members
    • 11.1.12. Sep 11, 2013: United Therapeutics Announces FDA Acceptance of Second Resubmission of Oral Treprostinil NDA
    • 11.1.13. Aug 19, 2013: Orthofix Receives Expected NASDAQ Notice Related to Late Filing of Form 10-Q
  • 11.2. Financial Announcements
    • 11.2.1. May 07, 2014: Orthofix International Reports First Quarter 2014 Results
    • 11.2.2. Mar 27, 2014: Orthofix International Provides Fourth Quarter and Full-Year 2013 Results
    • 11.2.3. Jul 29, 2013: Orthofix Postpones Second Quarter Earnings Release and Investor Conference Call
    • 11.2.4. Jul 17, 2013: Orthofix International Announces Date For Release of Second Quarter 2013 Results
  • 11.3. Legal And Regulatory
    • 11.3.1. Aug 16, 2013: Glancy Binkow & Goldberg Announces Class Action Lawsuit Against Orthofix International
  • 11.4. Other Significant Developments
    • 11.4.1. Jan 08, 2014: BIOTRONIK Devices and Leads, including latest DX System Technology, Now Available for Veterans Affairs Clients
  • 11.5. Product News
    • 11.5.1. Jan 27, 2014: Laerdal Medical and Wolters Kluwer Health Introduce Virtual Simulation Learning Tool for Nursing Students
    • 11.5.2. Dec 20, 2013: First-in-Man Implantation of CARMAT's Bioprosthetic Artificial Heart
  • 11.6. Strategy And Business Planning
    • 11.6.1. Jun 20, 2013: Orthofix Realigns Business Units To Support Future Growth Opportunities

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Market Modeling and Forecasting
    • 12.1.5. Company Share Analysis
    • 12.1.6. Distribution Share Analysis
  • 12.2. Expert Panel
  • 12.3. GlobalData Consulting
  • 12.4. Contact Us
  • 12.5. Disclaimer

List of Tables

  • Table 1: Cardiac Rhythm Management Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2005-2020
  • Table 2: Cardiac Rhythm Management Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Table 3: Cardiac Rhythm Management Market, EU5, Revenue ($m), Historic, USD Constant, 2005-2012
  • Table 4: Cardiac Rhythm Management Market, EU5, Revenue ($m), Forecast, USD Constant, 2012-2020
  • Table 5: Cardiac Rhythm Management Market, EU5, Volume (Units), 2005-2020
  • Table 6: Cardiac Rhythm Management Market, EU5, Volume (Units), Historic, 2005-2012
  • Table 7: Cardiac Rhythm Management Market, EU5, Volume (Units), Forecast, 2012-2020
  • Table 8: Cardiac Rhythm Management Market, EU5, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 9: Cardiac Rhythm Management Market, France, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 10: Cardiac Rhythm Management Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 11: Cardiac Resynchronisation Therapy Market, France, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 12: Implantable Cardioverter Defibrillators Market, France, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 13: Pacemakers Market, France, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 14: Cardiac Resynchronisation Therapy Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 15: Implantable Cardioverter Defibrillators Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 16: Pacemakers Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 17: Cardiac Rhythm Management Market, France, Volume (Units), Historic, 2005-2012
  • Table 18: Cardiac Rhythm Management Market, France, Volume (Units), Forecast, 2012-2020
  • Table 19: Cardiac Resynchronisation Therapy Market, France, Volume (Units), Historic, 2005-2012
  • Table 20: Implantable Cardioverter Defibrillators Market, France, Volume (Units), Historic, 2005-2012
  • Table 21: Pacemakers Market, France, Volume (Units), Historic, 2005-2012
  • Table 22: Cardiac Resynchronisation Therapy Market, France, Volume (Units), Forecast, 2012-2020
  • Table 23: Implantable Cardioverter Defibrillators Market, France, Volume (Units), Forecast, 2012-2020
  • Table 24: Pacemakers Market, France, Volume (Units), Forecast, 2012-2020
  • Table 25: Cardiac Rhythm Management Market, France, Average Price ($), Historic, 2005-2012
  • Table 26: Cardiac Rhythm Management Market, France, Average Price ($), Forecast, 2012-2020
  • Table 27: Cardiac Rhythm Management Market, France, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 28: Cardiac Rhythm Management Market, France, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 29: Cardiac Rhythm Management Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 30: Cardiac Rhythm Management Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 31: Cardiac Resynchronisation Therapy Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 32: Implantable Cardioverter Defibrillators Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 33: Pacemakers Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 34: Cardiac Resynchronisation Therapy Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 35: Implantable Cardioverter Defibrillators Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 36: Pacemakers Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 37: Cardiac Rhythm Management Market, Germany, Volume (Units), Historic, 2005-2012
  • Table 38: Cardiac Rhythm Management Market, Germany, Volume (Units), Forecast, 2012-2020
  • Table 39: Cardiac Resynchronisation Therapy Market, Germany, Volume (Units), Historic, 2005-2012
  • Table 40: Implantable Cardioverter Defibrillators Market, Germany, Volume (Units), Historic, 2005-2012
  • Table 41: Pacemakers Market, Germany, Volume (Units), Historic, 2005-2012
  • Table 42: Cardiac Resynchronisation Therapy Market, Germany, Volume (Units), Forecast, 2012-2020
  • Table 43: Implantable Cardioverter Defibrillators Market, Germany, Volume (Units), Forecast, 2012-2020
  • Table 44: Pacemakers Market, Germany, Volume (Units), Forecast, 2012-2020
  • Table 45: Cardiac Rhythm Management Market, Germany, Average Price ($), Historic, 2005-2012
  • Table 46: Cardiac Rhythm Management Market, Germany, Average Price ($), Forecast, 2012-2020
  • Table 47: Cardiac Rhythm Management Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 48: Cardiac Rhythm Management Market, Germany, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 49: Cardiac Rhythm Management Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 50: Cardiac Rhythm Management Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 51: Cardiac Resynchronisation Therapy Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 52: Implantable Cardioverter Defibrillators Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 53: Pacemakers Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 54: Cardiac Resynchronisation Therapy Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 55: Implantable Cardioverter Defibrillators Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 56: Pacemakers Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 57: Cardiac Rhythm Management Market, Italy, Volume (Units), Historic, 2005-2012
  • Table 58: Cardiac Rhythm Management Market, Italy, Volume (Units), Forecast, 2012-2020
  • Table 59: Cardiac Resynchronisation Therapy Market, Italy, Volume (Units), Historic, 2005-2012
  • Table 60: Implantable Cardioverter Defibrillators Market, Italy, Volume (Units), Historic, 2005-2012
  • Table 61: Pacemakers Market, Italy, Volume (Units), Historic, 2005-2012
  • Table 62: Cardiac Resynchronisation Therapy Market, Italy, Volume (Units), Forecast, 2012-2020
  • Table 63: Implantable Cardioverter Defibrillators Market, Italy, Volume (Units), Forecast, 2012-2020
  • Table 64: Pacemakers Market, Italy, Volume (Units), Forecast, 2012-2020
  • Table 65: Cardiac Rhythm Management Market, Italy, Average Price ($), Historic, 2005-2012
  • Table 66: Cardiac Rhythm Management Market, Italy, Average Price ($), Forecast, 2012-2020
  • Table 67: Cardiac Rhythm Management Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 68: Cardiac Rhythm Management Market, Italy, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 69: Cardiac Rhythm Management Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 70: Cardiac Rhythm Management Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 71: Cardiac Resynchronisation Therapy Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 72: Implantable Cardioverter Defibrillators Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 73: Pacemakers Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 74: Cardiac Resynchronisation Therapy Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 75: Implantable Cardioverter Defibrillators Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 76: Pacemakers Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 77: Cardiac Rhythm Management Market, Spain, Volume (Units), Historic, 2005-2012
  • Table 78: Cardiac Rhythm Management Market, Spain, Volume (Units), Forecast, 2012-2020
  • Table 79: Cardiac Resynchronisation Therapy Market, Spain, Volume (Units), Historic, 2005-2012
  • Table 80: Implantable Cardioverter Defibrillators Market, Spain, Volume (Units), Historic, 2005-2012
  • Table 81: Pacemakers Market, Spain, Volume (Units), Historic, 2005-2012
  • Table 82: Cardiac Resynchronisation Therapy Market, Spain, Volume (Units), Forecast, 2012-2020
  • Table 83: Implantable Cardioverter Defibrillators Market, Spain, Volume (Units), Forecast, 2012-2020
  • Table 84: Pacemakers Market, Spain, Volume (Units), Forecast, 2012-2020
  • Table 85: Cardiac Rhythm Management Market, Spain, Average Price ($), Historic, 2005-2012
  • Table 86: Cardiac Rhythm Management Market, Spain, Average Price ($), Forecast, 2012-2020
  • Table 87: Cardiac Rhythm Management Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 88: Cardiac Rhythm Management Market, Spain, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 89: Cardiac Rhythm Management Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 90: Cardiac Rhythm Management Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 91: Cardiac Resynchronisation Therapy Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 92: Implantable Cardioverter Defibrillators Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 93: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 94: Cardiac Resynchronisation Therapy Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 95: Implantable Cardioverter Defibrillators Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 96: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 97: Cardiac Rhythm Management Market, United Kingdom, Volume (Units), Historic, 2005-2012
  • Table 98: Cardiac Rhythm Management Market, United Kingdom, Volume (Units), Forecast, 2012-2020
  • Table 99: Cardiac Resynchronisation Therapy Market, United Kingdom, Volume (Units), Historic, 2005-2012
  • Table 100: Implantable Cardioverter Defibrillators Market, United Kingdom, Volume (Units), Historic, 2005-2012
  • Table 101: Pacemakers Market, United Kingdom, Volume (Units), Historic, 2005-2012
  • Table 102: Cardiac Resynchronisation Therapy Market, United Kingdom, Volume (Units), Forecast, 2012-2020
  • Table 103: Implantable Cardioverter Defibrillators Market, United Kingdom, Volume (Units), Forecast, 2012-2020
  • Table 104: Pacemakers Market, United Kingdom, Volume (Units), Forecast, 2012-2020
  • Table 105: Cardiac Rhythm Management Market, United Kingdom, Average Price ($), Historic, 2005-2012
  • Table 106: Cardiac Rhythm Management Market, United Kingdom, Average Price ($), Forecast, 2012-2020
  • Table 107: Cardiac Rhythm Management Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 108: Cardiac Rhythm Management Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 109: Cardiac Rhythm Management Market Pipeline Products
  • Table 110: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures

  • Figure 1: Cardiac Rhythm Management Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2005-2020
  • Figure 2: Cardiac Rhythm Management Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Figure 3: Cardiac Rhythm Management Market, EU5, Revenue ($m), Historic, USD Constant, 2005-2012
  • Figure 4: Cardiac Rhythm Management Market, EU5, Revenue ($m), Forecast, USD Constant, 2012-2020
  • Figure 5: Cardiac Rhythm Management Market, EU5, Volume (Units), 2005-2020
  • Figure 6: Cardiac Rhythm Management Market, EU5, Volume (Units), Historic, 2005-2012
  • Figure 7: Cardiac Rhythm Management Market, EU5, Volume (Units), Forecast, 2012-2020
  • Figure 8: Cardiac Rhythm Management Market, EU5, Company Share (%), 2012
  • Figure 9: Cardiac Rhythm Management Market, France, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 10: Cardiac Rhythm Management Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 11: Cardiac Resynchronisation Therapy Market, France, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 12: Implantable Cardioverter Defibrillators Market, France, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 13: Pacemakers Market, France, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 14: Cardiac Resynchronisation Therapy Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 15: Implantable Cardioverter Defibrillators Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 16: Pacemakers Market, France, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 17: Cardiac Rhythm Management Market, France, Volume (Units), Historic, 2005-2012
  • Figure 18: Cardiac Rhythm Management Market, France, Volume (Units), Forecast, 2012-2020
  • Figure 19: Cardiac Resynchronisation Therapy Market, France, Volume (Units), Historic, 2005-2012
  • Figure 20: Implantable Cardioverter Defibrillators Market, France, Volume (Units), Historic, 2005-2012
  • Figure 21: Pacemakers Market, France, Volume (Units), Historic, 2005-2012
  • Figure 22: Cardiac Resynchronisation Therapy Market, France, Volume (Units), Forecast, 2012-2020
  • Figure 23: Implantable Cardioverter Defibrillators Market, France, Volume (Units), Forecast, 2012-2020
  • Figure 24: Pacemakers Market, France, Volume (Units), Forecast, 2012-2020
  • Figure 25: Cardiac Rhythm Management Market, France, Company Share (%) 2012
  • Figure 26: Cardiac Rhythm Management Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 27: Cardiac Rhythm Management Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 28: Cardiac Resynchronisation Therapy Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 29: Implantable Cardioverter Defibrillators Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 30: Pacemakers Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 31: Cardiac Resynchronisation Therapy Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 32: Implantable Cardioverter Defibrillators Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 33: Pacemakers Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 34: Cardiac Rhythm Management Market, Germany, Volume (Units), Historic, 2005-2012
  • Figure 35: Cardiac Rhythm Management Market, Germany, Volume (Units), Forecast, 2012-2020
  • Figure 36: Cardiac Resynchronisation Therapy Market, Germany, Volume (Units), Historic, 2005-2012
  • Figure 37: Implantable Cardioverter Defibrillators Market, Germany, Volume (Units), Historic, 2005-2012
  • Figure 38: Pacemakers Market, Germany, Volume (Units), Historic, 2005-2012
  • Figure 39: Cardiac Resynchronisation Therapy Market, Germany, Volume (Units), Forecast, 2012-2020
  • Figure 40: Implantable Cardioverter Defibrillators Market, Germany, Volume (Units), Forecast, 2012-2020
  • Figure 41: Pacemakers Market, Germany, Volume (Units), Forecast, 2012-2020
  • Figure 42: Cardiac Rhythm Management Market, Germany, Company Share (%) 2012
  • Figure 43: Cardiac Rhythm Management Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 44: Cardiac Rhythm Management Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 45: Cardiac Resynchronisation Therapy Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 46: Implantable Cardioverter Defibrillators Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 47: Pacemakers Market, Italy, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 48: Cardiac Resynchronisation Therapy Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 49: Implantable Cardioverter Defibrillators Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 50: Pacemakers Market, Italy, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 51: Cardiac Rhythm Management Market, Italy, Volume (Units), Historic, 2005-2012
  • Figure 52: Cardiac Rhythm Management Market, Italy, Volume (Units), Forecast, 2012-2020
  • Figure 53: Cardiac Resynchronisation Therapy Market, Italy, Volume (Units), Historic, 2005-2012
  • Figure 54: Implantable Cardioverter Defibrillators Market, Italy, Volume (Units), Historic, 2005-2012
  • Figure 55: Pacemakers Market, Italy, Volume (Units), Historic, 2005-2012
  • Figure 56: Cardiac Resynchronisation Therapy Market, Italy, Volume (Units), Forecast, 2012-2020
  • Figure 57: Implantable Cardioverter Defibrillators Market, Italy, Volume (Units), Forecast, 2012-2020
  • Figure 58: Pacemakers Market, Italy, Volume (Units), Forecast, 2012-2020
  • Figure 59: Cardiac Rhythm Management Market, Italy, Company Share (%), 2012
  • Figure 60: Cardiac Rhythm Management Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 61: Cardiac Rhythm Management Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 62: Cardiac Resynchronisation Therapy Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 63: Implantable Cardioverter Defibrillators Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 64: Pacemakers Market, Spain, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 65: Cardiac Resynchronisation Therapy Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 66: Implantable Cardioverter Defibrillators Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 67: Pacemakers Market, Spain, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 68: Cardiac Rhythm Management Market, Spain, Volume (Units), Historic, 2005-2012
  • Figure 69: Cardiac Rhythm Management Market, Spain, Volume (Units), Forecast, 2012-2020
  • Figure 70: Cardiac Resynchronisation Therapy Market, Spain, Volume (Units), Historic, 2005-2012
  • Figure 71: Implantable Cardioverter Defibrillators Market, Spain, Volume (Units), Historic, 2005-2012
  • Figure 72: Pacemakers Market, Spain, Volume (Units), Historic, 2005-2012
  • Figure 73: Cardiac Resynchronisation Therapy Market, Spain, Volume (Units), Forecast, 2012-2020
  • Figure 74: Implantable Cardioverter Defibrillators Market, Spain, Volume (Units), Forecast, 2012-2020
  • Figure 75: Pacemakers Market, Spain, Volume (Units), Forecast, 2012-2020
  • Figure 76: Cardiac Rhythm Management Market, Spain, Company Share (%) 2012
  • Figure 77: Cardiac Rhythm Management Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 78: Cardiac Rhythm Management Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 79: Cardiac Resynchronisation Therapy Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 80: Implantable Cardioverter Defibrillators Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 81: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 82: Cardiac Resynchronisation Therapy Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 83: Implantable Cardioverter Defibrillators Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 84: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 85: Cardiac Rhythm Management Market, United Kingdom, Volume (Units), Historic, 2005-2012
  • Figure 86: Cardiac Rhythm Management Market, United Kingdom, Volume (Units), Forecast, 2012-2020
  • Figure 87: Cardiac Resynchronisation Therapy Market, United Kingdom, Volume (Units), Historic, 2005-2012
  • Figure 88: Implantable Cardioverter Defibrillators Market, United Kingdom, Volume (Units), Historic, 2005-2012
  • Figure 89: Pacemakers Market, United Kingdom, Volume (Units), Historic, 2005-2012
  • Figure 90: Cardiac Resynchronisation Therapy Market, United Kingdom, Volume (Units), Forecast, 2012-2020
  • Figure 91: Implantable Cardioverter Defibrillators Market, United Kingdom, Volume (Units), Forecast, 2012-2020
  • Figure 92: Pacemakers Market, United Kingdom, Volume (Units), Forecast, 2012-2020
  • Figure 93: Cardiac Rhythm Management Market, United Kingdom, Company Share (%), 2012
  • Figure 94: GlobalData Epidemiology-Based Forecasting Model
  • Figure 95: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 96: Primary Interviews by Participant Type (%)
Back to Top